Publications by authors named "Serghei Popa"

Claim this Profile
F
Fine-Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection.
Wei Gao, Andrea L Webber, Jill Maxwell, Melanie Anderson, Luzelena Caro, Serghei Popa

Clin Pharmacol Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiviral Activity, Safety, and Tolerability of Multiple Ascending Doses of Elbasvir or Grazoprevir in Participants Infected With Hepatitis C Virus Genotype-1 or -3.
Wendy W Yeh, Iain P Fraser, Patricia Jumes, Amelia Petry, Inge De Lepeleire, Serghei Popa

Clin Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A CCR2/5 Inhibitor, PF-04634817, Is Inferior to Monthly Ranibizumab in the Treatment of Diabetic Macular Edema.
Jeremy D Gale, Brian Berger, Steven Gilbert, Serghei Popa, Marla B Sultan

Invest Ophthalmol Vis Sci· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual IL-17A and IL-17F neutralisation by bimekizumab in psoriatic arthritis: evidence from preclinical experiments and a randomised placebo-controlled clinical trial that IL-17F contributes to human chronic tissue inflammation.
Sophie Glatt, Dominique Baeten, Terry Baker, Meryn Griffiths, Lucian Ionescu, Serghei Popa

Ann Rheum Dis· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Magnetic resonance imaging of the hand and wrist in a randomized, double-blind, multicenter, placebo-controlled trial of infliximab for rheumatoid arthritis: Comparison of dynamic contrast enhanced assessments with semi-quantitative scoring.
Chan Beals, Richard Baumgartner, Charles Peterfy, Andra Balanescu, Gavrila Mirea, Serghei Popa

PLoS One· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial.
Daniel J Wallace, Vibeke Strand, Joan T Merrill, Serghei Popa, Alberto J Spindler

Ann Rheum Dis· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dipeptidyl peptidase-4 inhibition in patients with type 2 diabetes treated with saxagliptin, sitagliptin, or vildagliptin.
Daniel A Tatosian, Ying Guo, Andrea K Schaeffer, Natalia Gaibu, Serghei Popa

Diabetes Ther· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis